Spero Therapeutics SPRO
NASDAQ SPRO
$1.13 -0.04 (-3.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Price to Earnings (2023 - 2026)

Updated

Spero Therapeutics' (SPRO) Price to Earnings was 17.38 for Q2 2026, up 95.6% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Price to Earnings (2023 - 2026) Analysis & Trends

For FY2025, Price to Earnings at Spero Therapeutics was 15.28.

  • By year, Price to Earnings came in at 3.42 in FY2023.
  • The Q2 2026 figure ranks as the highest quarterly Price to Earnings since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Spero Therapeutics 65.71 Mn -130.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.38
Mar 31, 2026 8.89
Dec 31, 2025 15.38
Sep 30, 2024 21.04
Jun 30, 2024 4.03
Mar 31, 2024 3.96
Dec 31, 2023 3.41
API Access

Spero Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SPRO&period=max&api_key=YOUR_API_KEY